Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review
about
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments TrialsHIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusionGenomic Disruption of VEGF-A Expression in Human Retinal Pigment Epithelial Cells Using CRISPR-Cas9 Endonuclease.Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFα-induced angiogenesisSYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Inhibitory effect of tenomodulin versus ranibizumab on in vitro angiogenesis.Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration.A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015.Evolution of Intravitreal Therapy for Retinal Diseases - From CMV to CNV: The LXXIV Edward Jackson Memorial Lecture.Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice.
P2860
Q28049700-BFE9DDDD-0CAD-4AC6-BFD8-C69E1C651B82Q30491978-487183E6-F2EC-4FAB-BD4D-0B7B1E8D546FQ36186327-68267327-E267-46D2-892E-56BE5008D543Q37354230-74A7F525-2287-4828-8B9D-A1113D4B8A07Q37680056-2EAA8802-30F5-4F1F-A232-D69A2F2D9D21Q39550796-42300D2C-C5FD-47CB-8C4E-57FDBC9D4AE5Q40061856-9588D39A-D2FB-4818-B7E1-C0529369F060Q42374470-1740FB36-0783-4CD9-8EB4-78ECF5675BE2Q45648693-F674899C-8BB3-400D-822B-366082778C62Q47729194-A7EB2DB3-542E-44B0-AD7C-F3ADC480DDDBQ50583158-A95E2DED-B085-4023-8065-DAC5BFEDDABD
P2860
Intravitreal Bevacizumab Versus Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration: Findings from a Cochrane Systematic Review
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@ast
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@en
type
label
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@ast
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@en
prefLabel
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@ast
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@en
P2093
P2860
P1433
P1476
Intravitreal Bevacizumab Versu ...... m a Cochrane Systematic Review
@en
P2093
Barbara S Hawkins
Kristina B Lindsley
Magdalena G Krzystolik
Satyanarayana S Vedula
Sharon D Solomon
P2860
P304
P356
10.1016/J.OPHTHA.2015.09.002
P577
2015-10-15T00:00:00Z